» Authors » Pedro Mendes-Bastos

Pedro Mendes-Bastos

Explore the profile of Pedro Mendes-Bastos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 297
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Duarte B, Mendes-Bastos P, Antunes J, Azevedo F, Goncalo M, Henrique M, et al.
Dermatol Ther (Heidelb) . 2025 Feb; 15(3):647-662. PMID: 39930312
Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease with a substantial impact on patients' quality of life (QoL). This study aimed to characterize the burden of moderate-to-severe AD...
2.
Torres T, Mendes-Bastos P, Cruz M, Duarte B, Filipe P, Lopes M, et al.
Dermatol Ther (Heidelb) . 2025 Feb; 15(3):579-597. PMID: 39930311
Atopic dermatitis (AD) is a common chronic inflammatory skin condition that significantly impairs patients' quality of life as a result of intense itching and persistent eczematous lesions. Although AD has...
3.
Henriques A, Pimentel-Santos F, Teles de Sousa J, Silva L, Gago L, Emilia Santos M, et al.
ARP Rheumatol . 2025 Jan; 3(4):258-267. PMID: 39754727
Background: The percentage of Portuguese psoriasis patients with psoriatic arthritis is unknown but musculoskeletal complaints related to PsA affect up to a third of patients. Dermatologists can identify early PsA...
4.
Mastorino L, Mendes-Bastos P, Ribero S, Ortoncelli M
Clin Exp Dermatol . 2024 Dec; PMID: 39670733
No abstract available.
5.
6.
Paller A, Mendes-Bastos P, Siegfried E, Eichenfield L, Soong W, Prajapati V, et al.
JAMA Dermatol . 2024 Oct; 160(12):1304-1313. PMID: 39441580
Importance: The Measure Up 1, Measure Up 2, and AD Up studies demonstrated the efficacy and adverse events of upadacitinib through 52 weeks in adults and adolescents with atopic dermatitis...
7.
Silverberg J, Bunick C, Hong H, Mendes-Bastos P, Gold L, Costanzo A, et al.
Br J Dermatol . 2024 Oct; 192(1):36-45. PMID: 39438067
Background: Atopic dermatitis (AD) is a chronic skin disease characterized by intense itch and eczematous skin lesions. Some patients with AD continue to experience flares and substantial clinical burden, despite...
8.
Mastorino L, Ribero S, Burlando M, Mendes-Bastos P
Front Med (Lausanne) . 2024 Oct; 11:1473753. PMID: 39359916
No abstract available.
9.
Mendes-Bastos P, Benhadou F, Venturini M, Molina-Levya A, Thomas N, Alarcon I, et al.
Front Med (Lausanne) . 2024 Jul; 11:1403455. PMID: 39040895
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease with a profound disease burden. In recent years, the advent of biologic therapies has improved the treatment landscape for patients with...
10.
Yosipovitch G, Kim B, Kwatra S, Mollanazar N, Stander S, Satoh T, et al.
JAAD Int . 2024 Jul; 16:163-174. PMID: 39006917
Background: Phase 3 PRIME/PRIME2 trials independently demonstrated efficacy and an acceptable safety profile of dupilumab adults with moderate-to-severe prurigo nodularis. Objective: To obtain a more precise estimate of onset and...